BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5019567)

  • 1. Estradiol analogs with conformational flexibility. 4-(1,2,3,4-Tetrahydro-6-hydroxy-2-naphthyl)-butan-2-ol.
    Rao PN; Buss DH; Axelrod LR
    J Med Chem; 1972 Apr; 15(4):426-7. PubMed ID: 5019567
    [No Abstract]   [Full Text] [Related]  

  • 2. An anti-estradiol effect of ent-estradiol-17beta (1-estradiol).
    Edgren RA; Jones RC
    Steroids; 1969 Sep; 14(3):335-41. PubMed ID: 5821989
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogenicity of a new antifertility compound E-696, a 3-substitute of 2, 2-dimethyl alkanoic acid.
    Mehrotra PK; Kamboj VP
    Indian J Exp Biol; 1977 Dec; 15(12):1195-7. PubMed ID: 614218
    [No Abstract]   [Full Text] [Related]  

  • 4. 4-(6-Methoxy-2-naphthyl)butan-2-one and related analogues, a novel structural class of antiinflammatory compounds.
    Goudie AC; Gaster LM; Lake AW; Rose CJ; Freeman PC; Hughes BO; Miller D
    J Med Chem; 1978 Dec; 21(12):1260-4. PubMed ID: 722734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convenient synthesis of 1,1-disubstituted 1,4-butanediols and derivatives.
    Umio S; Ueda I; Nojima H
    J Med Chem; 1972 Aug; 15(8):855-6. PubMed ID: 5044305
    [No Abstract]   [Full Text] [Related]  

  • 6. Mammalian antifertility agents. VI. A novel sequence for the preparation of 1,2-disubstituted 3,4-dihydronaphthalenes.
    Lednicer D; Emmert DE; Lyster SC; Duncan GW
    J Med Chem; 1969 Sep; 12(5):881-5. PubMed ID: 5812203
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of hormone analogs containing the p-hydroxybenzyl group.
    Lynch DM; Cole W
    J Med Chem; 1968 Mar; 11(2):291-5. PubMed ID: 5663620
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies in antifertility agents. 8. Seco steroids. 2. 5,6-Secoestradiol and some related compounds.
    Bindra JS; Neyyarapally AT; Gupta RC; Kamboj VP; Anand N
    J Med Chem; 1975 Sep; 18(9):921-5. PubMed ID: 1159714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [11-azasteroids. V. Hormonal properties of 11-azaestranes].
    Ivanenko TI; Pivnitskiĭ KK; Fedotov VP
    Probl Endokrinol (Mosk); 1979; 25(1):62-8. PubMed ID: 419093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of estradiol, ethynylestradiol, and moxestrol in rat uterus, vagina, and aorta: influence of sex steroid treatment.
    Blom MJ; Wassink MG; Kloosterboer HJ; Ederveen AG; Lambert JG; Goos HJ
    Drug Metab Dispos; 2001 Jan; 29(1):76-81. PubMed ID: 11124233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogenic profile of 8-azaethynylestradiol.
    Rassaert CL; Richter RS; Brown RE; DiPasquale G
    Steroids Lipids Res; 1972; 3(2):185-92. PubMed ID: 4657992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological activity of modified analogs of steroid estrogens. Racemic 8-isoestradiol].
    Nikitina GV; Korkhov VV; Shavva AG
    Farmakol Toksikol; 1984; 47(4):88-91. PubMed ID: 6479318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on physiology & biochemistry of female genital tract: response of uterus, cervix & vagina of albino rats to cis- & trans-clomiphene in the presence or absence of estrogen.
    Karkun JN; Mehrotra PK
    Indian J Exp Biol; 1973 Jan; 11(1):7-14. PubMed ID: 4779300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3,5(10)-Estratrien-17 -yl enol ethers and acetals. New classes of orally and parenterally active estrogenic derivatives.
    Gardi R; Vitali R; Falconi G; Ercoli A
    J Med Chem; 1973 Feb; 16(2):123-7. PubMed ID: 4683106
    [No Abstract]   [Full Text] [Related]  

  • 15. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. Trans-6-[2-(substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Prugh JD; Alberts AW; Deana AA; Gilfillian JL; Huff JW; Smith RL; Wiggins JM
    J Med Chem; 1990 Feb; 33(2):758-65. PubMed ID: 2299642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogenicity of some nonsteroidal compounds.
    Mehrotra PK; Karkun JN; Kar AB
    Indian J Exp Biol; 1974 Mar; 12(2):133-5. PubMed ID: 4435843
    [No Abstract]   [Full Text] [Related]  

  • 17. The relative potencies of oestriol, oestradiol and oestrone on the uterus and vagina of the mouse.
    Miller BG
    J Endocrinol; 1969 Apr; 43(4):563-70. PubMed ID: 5767689
    [No Abstract]   [Full Text] [Related]  

  • 18. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
    Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
    J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of estradiol (E2) with those of octylmethoxycinnamate (OMC) and 4-methylbenzylidene camphor (4MBC)--2 filters of UV light - on several uterine, vaginal and bone parameters.
    Seidlová-Wuttke D; Jarry H; Christoffel J; Rimoldi G; Wuttke W
    Toxicol Appl Pharmacol; 2006 Feb; 210(3):246-54. PubMed ID: 15979666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 3-(3,4-dihydro-6-methoxy-2-naphthyl)2,2-dimethyl pentanoic acid--an antifertility agent--on in vitro uptake of estradiol 17beta-6, 7(3)-H in rat uterus.
    Ghosh M; Roy SK; Gopalchari R
    Indian J Exp Biol; 1976 Sep; 14(5):620-1. PubMed ID: 1024987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.